| Shortest distance to current term (+ for parents, - for children) |
CC term [CC ID] <#Children> |
#Domains (Superfamily|Family) |
#Supra-domain (Single|Duplex|Triple) |
| + + + + + 5: | Chemicals [MESH:D] <13> |
| + + + + 4: | Polycyclic Compounds [MESH:D011083] <191> | (419|579) |
(431|390|204) |
| + + + 3: | Pregnanes [MESH:D011278] <122> | (50|60) |
(52|29|14) |
| + + + 3: | Fused-Ring Compounds [MESH:D000072473] <2> | (146|200) |
(156|135|57) |
| + + 2: | Steroids [MESH:D013256] <415> | (116|152) |
(126|85|35) |
| + + 2: | Pregnadienes [MESH:D011245] <43> | (23|21) |
(24|14|5) |
| + 1: | Pregnadienetriols [MESH:D011246] <12> | (17|17) |
(19|12|4) |
| + 1: | Steroids, Fluorinated [MESH:D013259] <12> | (8|8) |
(8|6|2) |
| 0: | Dexamethasone [MESH:D003907] <138> | (3|4) |
(3|5|2) |
| - 1: | Dexamethasone Isonicotinate [MESH:D003908] <3> | (0|0) |
(0|0|0) |
| - 1: | Desoximetasone [MESH:D003899] <2> | (0|0) |
(0|0|0) |
| - 1: | 11-dehydrodexamethasone [MESH:C528116] | (0|0) |
(0|0|0) |
| - 1: | 11-ketodexamethasone [MESH:C484907] | (0|0) |
(0|0|0) |
| - 1: | 21-((aminopropyl)thio)dexamethasone [MESH:C022781] | (0|0) |
(0|0|0) |
| - 1: | 21-((mercaptobutyl)thio)dexamethasone [MESH:C022829] | (0|0) |
(0|0|0) |
| - 1: | 21-benzyloxy-9alpha-fluoro-16alpha-methylpregna-1,4-dien-11beta,17alpha-diol-3,20-dione [MESH:C480824] | (0|0) |
(0|0|0) |
| - 1: | 4-(carboxymethylthio)dexamethasone [MESH:C067202] | (0|0) |
(0|0|0) |
| - 1: | 6-hydroxydexamethasone [MESH:C051956] | (0|0) |
(0|0|0) |
| - 1: | 6-hydroxydexamethasone 17-propionate [MESH:C059543] | (0|0) |
(0|0|0) |
| - 1: | ALL-85 protocol [MESH:C471582] | (0|0) |
(0|0|0) |
| - 1: | ALL-VI protocol [MESH:C407162] | (0|0) |
(0|0|0) |
| - 1: | BACOD protocol [MESH:C076190] | (0|0) |
(0|0|0) |
| - 1: | BACOD-VP16 protocol [MESH:C075090] | (0|0) |
(0|0|0) |
| - 1: | BBVDD protocol [MESH:C071786] | (0|0) |
(0|0|0) |
| - 1: | BFM-ALL 81 protocol [MESH:C083136] | (0|0) |
(0|0|0) |
| - 1: | BMPD protocol [MESH:C114848] | (0|0) |
(0|0|0) |
| - 1: | Berlin-Frankfurt-Muenster protocol II [MESH:C464579] | (0|0) |
(0|0|0) |
| - 1: | CAD protocol 3 [MESH:C427343] | (0|0) |
(0|0|0) |
| - 1: | CBVD protocol [MESH:C039085] | (0|0) |
(0|0|0) |
| - 1: | CEOP-IMVP-Dexa regimen [MESH:C071944] | (0|0) |
(0|0|0) |
| - 1: | CEVAD protocol [MESH:C404862] | (0|0) |
(0|0|0) |
| - 1: | CEVD protocol [MESH:C089870] | (0|0) |
(0|0|0) |
| - 1: | CHASE protocol [MESH:C117413] | (0|0) |
(0|0|0) |
| - 1: | CIOD protocol [MESH:C484029] | (0|0) |
(0|0|0) |
| - 1: | CMD protocol [MESH:C118959] | (0|0) |
(0|0|0) |
| - 1: | CMED protocol [MESH:C066920] | (0|0) |
(0|0|0) |
| - 1: | CODBLAM IV protocol [MESH:C104095] | (0|0) |
(0|0|0) |
| - 1: | CVAD protocol [MESH:C064396] | (0|0) |
(0|0|0) |
| - 1: | CVAD-V protocol [MESH:C098386] | (0|0) |
(0|0|0) |
| - 1: | Cis-VACD protocol [MESH:C403746] | (0|0) |
(0|0|0) |
| - 1: | DAI protocol [MESH:C501864] | (0|0) |
(0|0|0) |
| - 1: | DCEP protocol [MESH:C465960] | (0|0) |
(0|0|0) |
| - 1: | DCTER protocol [MESH:C099839] | (0|0) |
(0|0|0) |
| - 1: | DEMOB protocol [MESH:C047596] | (0|0) |
(0|0|0) |
| - 1: | DFCI 91-01 protocol [MESH:C423864] | (0|0) |
(0|0|0) |
| - 1: | DFCI 95-01 protocol [MESH:C461483] | (0|0) |
(0|0|0) |
| - 1: | DHACT protocol [MESH:C110048] | (0|0) |
(0|0|0) |
| - 1: | DHAOx protocol [MESH:C451336] | (0|0) |
(0|0|0) |
| - 1: | DHAP protocol [MESH:C056642] | (0|0) |
(0|0|0) |
| - 1: | DICE protocol [MESH:C069295] | (0|0) |
(0|0|0) |
| - 1: | DIZE protocol [MESH:C403747] | (0|0) |
(0|0|0) |
| - 1: | DT PACE regimen [MESH:C542926] | (0|0) |
(0|0|0) |
| - 1: | DT-PACE protocol [MESH:C470178] | (0|0) |
(0|0|0) |
| - 1: | Dexa-BEAM protocol [MESH:C086095] | (0|0) |
(0|0|0) |
| - 1: | Dexa-PAMB protocol [MESH:C081520] | (0|0) |
(0|0|0) |
| - 1: | Doxiproct Plus [MESH:C011805] | (0|0) |
(0|0|0) |
| - 1: | EDAP regimen [MESH:C061181] | (0|0) |
(0|0|0) |
| - 1: | ESHAP regimen, modified [MESH:C452190] | (0|0) |
(0|0|0) |
| - 1: | EVDAC regimen [MESH:C084910] | (0|0) |
(0|0|0) |
| - 1: | FLUDAP protocol [MESH:C411476] | (0|0) |
(0|0|0) |
| - 1: | FND protocol [MESH:C086093] | (0|0) |
(0|0|0) |
| - 1: | G-IDEA protocol [MESH:C469705] | (0|0) |
(0|0|0) |
| - 1: | GDP protocol [MESH:C484028] | (0|0) |
(0|0|0) |
| - 1: | HCVAD protocol [MESH:C400080] | (0|0) |
(0|0|0) |
| - 1: | HEAVD protocol [MESH:C044678] | (0|0) |
(0|0|0) |
| - 1: | HR-1 protocol [MESH:C098983] | (0|0) |
(0|0|0) |
| - 1: | HR-2 protocol [MESH:C098984] | (0|0) |
(0|0|0) |
| - 1: | HR-3 protocol [MESH:C098985] | (0|0) |
(0|0|0) |
| - 1: | ICE protocol 2 [MESH:C088961] | (0|0) |
(0|0|0) |
| - 1: | LBCMVD-56 protocol [MESH:C418739] | (0|0) |
(0|0|0) |
| - 1: | M-BACOD protocol [MESH:C035353] | (0|0) |
(0|0|0) |
| - 1: | M-BNCOD protocol [MESH:C063463] | (0|0) |
(0|0|0) |
| - 1: | MAD protocol [MESH:C104354] | (0|0) |
(0|0|0) |
| - 1: | MCHOD protocol [MESH:C099767] | (0|0) |
(0|0|0) |
| - 1: | MDT protocol [MESH:C524336] | (0|0) |
(0|0|0) |
| - 1: | MEV-AD protocol [MESH:C059420] | (0|0) |
(0|0|0) |
| - 1: | MLL-93 protocol [MESH:C109456] | (0|0) |
(0|0|0) |
| - 1: | MOD protocol [MESH:C055795] | (0|0) |
(0|0|0) |
| - 1: | MV26PD protocol [MESH:C057981] | (0|0) |
(0|0|0) |
| - 1: | Metoclophen [MESH:C071457] | (0|0) |
(0|0|0) |
| - 1: | N-(dexamethasone 21-S-ethyl-2'-amino)tetramethylrhodamine [MESH:C046763] | (0|0) |
(0|0|0) |
| - 1: | NCX1021 [MESH:C515242] | (0|0) |
(0|0|0) |
| - 1: | ND8008 [MESH:C000613421] | (0|0) |
(0|0|0) |
| - 1: | Otomize [MESH:C071179] | (0|0) |
(0|0|0) |
| - 1: | PD protocol [MESH:C082619] | (0|0) |
(0|0|0) |
| - 1: | PETHEMA ALL-3-97 protocol [MESH:C482642] | (0|0) |
(0|0|0) |
| - 1: | ROAD-IN protocol [MESH:C412623] | (0|0) |
(0|0|0) |
| - 1: | Sofradex [MESH:C023881] | (0|0) |
(0|0|0) |
| - 1: | TCID protocol [MESH:C490149] | (0|0) |
(0|0|0) |
| - 1: | TVTG protocol [MESH:C512566] | (0|0) |
(0|0|0) |
| - 1: | Tobramycin, Dexamethasone Drug Combination [MESH:D000078162] | (0|0) |
(0|0|0) |
| - 1: | Tresaderm [MESH:C005679] | (0|0) |
(0|0|0) |
| - 1: | Ultra-demoplas [MESH:C002031] | (0|0) |
(0|0|0) |
| - 1: | VAD I protocol [MESH:C041041] | (0|0) |
(0|0|0) |
| - 1: | VAD protocol [MESH:C045351] | (0|0) |
(0|0|0) |
| - 1: | VAD regimen [MESH:C053329] | (0|0) |
(0|0|0) |
| - 1: | VBAD protocol [MESH:C078344] | (0|0) |
(0|0|0) |
| - 1: | VBAMDex protocol [MESH:C055592] | (0|0) |
(0|0|0) |
| - 1: | VCAD regimen [MESH:C075208] | (0|0) |
(0|0|0) |
| - 1: | VCD protocol [MESH:C407550] | (0|0) |
(0|0|0) |
| - 1: | VID protocol [MESH:C490148] | (0|0) |
(0|0|0) |
| - 1: | VIM-D protocol [MESH:C066535] | (0|0) |
(0|0|0) |
| - 1: | VMD protocol [MESH:C072507] | (0|0) |
(0|0|0) |
| - 1: | aminopyrine, dexamethasone, phenylbutazone, thiamine, vitamin B12 drug combination [MESH:C036446] | (0|0) |
(0|0|0) |
| - 1: | ascorbic acid, cysteamine, dexamethasone drug combination [MESH:C039186] | (0|0) |
(0|0|0) |
| - 1: | auricularum [MESH:C059464] | (0|0) |
(0|0|0) |
| - 1: | azidoamphenicol, clotrimazole, dexamethasone drug combination [MESH:C017051] | (0|0) |
(0|0|0) |
| - 1: | chloramphenicol, dexamethasone, neomycin drug combination [MESH:C512405] | (0|0) |
(0|0|0) |
| - 1: | chlorpromazine, dexamethasone, metoclopramide, orphenadrine drug combination [MESH:C050340] | (0|0) |
(0|0|0) |
| - 1: | clemastine, dexamethasone drug combination [MESH:C015760] | (0|0) |
(0|0|0) |
| - 1: | corticosteroid methanetriol mixture [MESH:C011244] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone 17-propionate [MESH:C059544] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone 17-valerate [MESH:C030949] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone 21-(beta-isothiocyanatoethyl)thioether [MESH:C069648] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone 21-bromoacetate [MESH:C034371] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone 21-glucoside [MESH:C040551] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone 21-iodoacetate [MESH:C034372] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone 21-methanesulfonate [MESH:C031710] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone 21-palmitate [MESH:C035081] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone 21-phenylpropionate [MESH:C035966] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone 21-phosphate [MESH:C004180] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone 21-tributylacetate [MESH:C032201] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone acetate [MESH:C018038] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone dipropionate [MESH:C059542] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone glucuronide [MESH:C095328] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone linoleate [MESH:C032172] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone oxetanone [MESH:C041706] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone succinate dextran [MESH:C481153] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone sulfate ester [MESH:C016356] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone trimethyl acetate [MESH:C022090] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone trioxa undecanoate [MESH:C079629] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone, dimethyllauryl benzylammonium, parachlorophenol, thymol drug combination [MESH:C041378] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone, neomycin, polymyxin B drug combination [MESH:C016070] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone-(C21-phosphoramide)-(anti-EGFR) [MESH:C000616332] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone-17-carboxamide [MESH:C040970] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone-21-sulfobenzoate [MESH:C079704] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone-FK506 heterodimer [MESH:C102348] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone-beta-cyclodextrin [MESH:C100693] | (0|0) |
(0|0|0) |
| - 1: | dexamethasone-bis-peptide nucleic acid [MESH:C464982] | (0|0) |
(0|0|0) |
| - 1: | exosterol [MESH:C007699] | (0|0) |
(0|0|0) |
| - 1: | hyperCDT protocol [MESH:C477838] | (0|0) |
(0|0|0) |
| - 1: | m-ACOD protocol [MESH:C070074] | (0|0) |
(0|0|0) |
| - 1: | m-BECOD protocol [MESH:C092090] | (0|0) |
(0|0|0) |
| - 1: | m-M-BACOD protocol [MESH:C065479] | (0|0) |
(0|0|0) |
| - 1: | neomycin sulfate, pyridine carboxylate of dexamethasone, tyzanol drug combination [MESH:C000886] | (0|0) |
(0|0|0) |
| - 1: | percutalgine [MESH:C575182] | (0|0) |
(0|0|0) |
| - 1: | supertendin [MESH:C093637] | (0|0) |
(0|0|0) |